134 related articles for article (PubMed ID: 4456482)
21. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Losert W; Hoder A; Scholz C
Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
[No Abstract] [Full Text] [Related]
22. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
Davidoff F
R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
[No Abstract] [Full Text] [Related]
23. [The effect of oral antidiabetics on the biosynthesis of proinsulin in the rat].
Tjioe TO; Wacker A
Arzneimittelforschung; 1972 Nov; 22(11):1890-2. PubMed ID: 4633587
[No Abstract] [Full Text] [Related]
24. When--and how--to use an oral agent.
Shuman CR
Med Times; 1980 May; 108(5):77-81, 85-6. PubMed ID: 7374409
[No Abstract] [Full Text] [Related]
25. [Effects of some sulfonylurea derivatives on liver extracts cultivated in vitro. I. Morphology].
Conti G; Hadhazy C; Cappelli B; Spreca A; Gotzos V
Pharm Acta Helv; 1971 Aug; 46(8):497-507. PubMed ID: 5092968
[No Abstract] [Full Text] [Related]
26. In vitro effect of various hypoglycemic agents on the hepatic and pancreatic protein synthesis in the rat.
Wacker A; Chandra P; Wacker D
Horm Metab Res; 1971 Sep; 3(5):357-8. PubMed ID: 5002750
[No Abstract] [Full Text] [Related]
27. The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts.
Lasseter KC; Levey GS; Palmer RF; McCarthy JS
J Clin Invest; 1972 Sep; 51(9):2429-34. PubMed ID: 4344732
[TBL] [Abstract][Full Text] [Related]
28. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
Augusti KT; Kurup PA
Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
[No Abstract] [Full Text] [Related]
29. [The blood-sugar depressing and betacytotrope effect of glibornurid in healthy and in gastric-resected persons (author's transl)].
Grabner W; Matzkies F; Randerbrock V; Berg G
Med Klin; 1973 Aug; 68(34):1101-5. PubMed ID: 4598149
[No Abstract] [Full Text] [Related]
30. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells.
Best L; Benington S
Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927
[TBL] [Abstract][Full Text] [Related]
31. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
[No Abstract] [Full Text] [Related]
32. [Comparative activity of some biguanides, sulfonylureas and their combinations on blood sugar and lactic acid in the guinea pig. II].
Bramanti G; Bianchini P; De Fina V; Dell'Omodarme G
Boll Chim Farm; 1971 Apr; 110(4):226-36. PubMed ID: 5111348
[No Abstract] [Full Text] [Related]
33. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
Brzozowski Z; Wójcikowski C
Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
[TBL] [Abstract][Full Text] [Related]
34. Glipentide and glucose metabolism in isolated rat hepatocytes.
López-Alarcón L; Berbil-Bautista PR; Guijarro C; Felíu JE
Biochem Pharmacol; 1988 Aug; 37(16):3177-82. PubMed ID: 2969730
[TBL] [Abstract][Full Text] [Related]
35. The pharmacology and metabolism of oral antidiabetic drugs.
Bänder A
Aust N Z J Med; 1971 Aug; 1():Suppl 2:22-30. PubMed ID: 5005129
[No Abstract] [Full Text] [Related]
36. Inhibition of catecholamine release by tolbutamide and other sulfonylureas.
Hsu CY; Brooker G; Peach MJ; Westfall TC
Science; 1975 Mar; 187(4181):1086-7. PubMed ID: 1114337
[TBL] [Abstract][Full Text] [Related]
37. [Effect of the sulfonylurea HB 419 (glibenclamide), tolbutamide and tolazamide on the lipolysis of isolated human fat cells].
Faulhaber JD; Ditschuneit H; Ditschuneit HH
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1476-8. PubMed ID: 5394469
[No Abstract] [Full Text] [Related]
38. Effect of sulphonylurea derivatives, SPC-703 and tolbutamide, on insulin binding by isolated rat adipocytes.
Skowroński R; Madrala A; Angielski S
Acta Biochim Pol; 1984; 31(2):251-62. PubMed ID: 6385586
[TBL] [Abstract][Full Text] [Related]
39. Oral hypoglycemic agents and heart.
Manoria P; Manoria P
Indian Heart J; 2007; 59(3):266-72. PubMed ID: 19124937
[No Abstract] [Full Text] [Related]
40. Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
Gylfe E; Hellman B
Mol Pharmacol; 1982 Nov; 22(3):715-20. PubMed ID: 7155128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
